Plain-English translation of NCT07316270 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing pulsed field ablation, a minimally invasive catheter procedure that can help restore normal heart rhythm in people with atrial fibrillation (irregular heartbeat) who have experienced a brain bleed. The study compares this procedure against standard care to see if it can reduce the risk of stroke and other serious complications while avoiding the bleeding risks associated with blood-thinning medications.
People with irregular heartbeat need blood thinners to prevent stroke, but these medications increase the risk of another brain bleed — creating a difficult choice between two serious dangers. This trial is testing whether the new treatment can restore normal heart rhythm and reduce or eliminate the need for long-term blood thinners, offering a safer path for these patients.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to the ablation group, you will undergo a catheter ablation procedure to restore your heart rhythm, followed by a short course of blood thinner medication for one month. If you are assigned to standard care, you will receive usual treatment for your condition. Both groups will have follow-up visits and monitoring for at least 2 years to track how you are doing and watch for any serious events like stroke or bleeding.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
China